RT Journal Article SR Electronic T1 Global profiling of SARS-CoV-2 specific IgG/ IgM responses of convalescents using a proteome microarray JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.03.20.20039495 DO 10.1101/2020.03.20.20039495 A1 Jiang, He-wei A1 Li, Yang A1 Zhang, Hai-nan A1 Wang, Wei A1 Men, Dong A1 Yang, Xiao A1 Qi, Huan A1 Zhou, Jie A1 Tao, Sheng-ce YR 2020 UL http://medrxiv.org/content/early/2020/03/27/2020.03.20.20039495.abstract AB COVID-19 is caused by SARS-CoV-2, and has become a global pandemic. There is no highly effective medicine or vaccine, most of the patients were recovered by their own immune response, especially the virus specific IgG and IgM responses. However, the IgG/ IgM responses is barely known. To enable the global understanding of SARS-CoV-2 specific IgG/ IgM responses, a SARS-CoV-2 proteome microarray with 18 out of the 28 predicted proteins was constructed. The microarray was applied to profile the IgG/ IgM responses with 29 convalescent sera. The results suggest that at the convalescent phase 100% of patients had IgG/ IgM responses to SARS-CoV-2, especially to protein N, S1 but not S2. S1 purified from mammalian cell demonstrated the highest performance to differentiate COVID-19 patients from controls. Besides protein N and S1, significant antibody responses to ORF9b and NSP5 were also identified. In-depth analysis showed that the level of S1 IgG positively correlate to age and the level of LDH (lactate dehydrogenase), especially for women, while the level of S1 IgG negatively correlate to Ly% (Lymphocyte percentage). This study presents the first whole picture of the SARS-CoV-2 specific IgG/ IgM responses, and provides insights to develop precise immuno-diagnostics, effective treatment and vaccine.HighlightsA SARS-CoV-2 proteome microarray contains 18 of the 28 predicted proteinsThe 1st global picture of the SARS-CoV-2 specific IgG/ IgM response reveals that at the convalescent phase, 100% of patients have IgG/ IgM responses to protein N and S1Significant antibody responses against ORF9b and NSP5 were identifiedProtein S1 specific IgG positively correlates to age and LDH, while negatively to Ly%Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by National Key Research and Development Program of China Grant (No. 2016YFA0500600), National Natural Science Foundation of China (No. 31970130, 31600672, 31670831, and 31370813).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe SARS-CoV-2 proteome microarray data are deposited on Protein Microarray Database (http://www.proteinmicroarray.cn) under the accession number PMDE241. Additional data related to this paper may be requested from the authors. http://www.proteinmicroarray.cn/index.php/experiment/detail?experiment_id=241